×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Clinical_Trial: 18F-PM-PBB3 PET Study in Tauopathy (NCT03625128)
clinical_trial
2,037 words
KG: ent-clin-68d86e34
2026-03-27
progressive-supranuclear-palsy
clinical-trial
pet-imaging
tau
tau-pet-tracer
4r-tauopathy
phase-1
nct03625128
Contents
18F-PM-PBB3 PET Study in Tauopathy (NCT03625128)
Knowledge Graph
Related Hypotheses (1)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Related Analyses (1)
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Related Experiments (6)
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40
Multiscale Computational Modeling of Protein Aggregation Kin
validation · proposed · Score: 0.40
PSP and CBS Biomarker Validation Study
clinical · proposed · Score: 0.40
Show 1 more